Group B Strep (GBS) Online Course
Evidence-based course for health professionals approved for 10 HOURS CPD/CE/CERPs. Includes clinical guidelines for UK, USA, CANADA, AUSTRALIA & NEW ZEALANDEnroll in Course
“I found this course very helpful. It was very well
presented, and I plan to update my informed choice about GBS and it's risks
with some new information I learned.”
- Karen, Home Birth Midwife, Wisconsin, USA
"I wanted to comment on the quality of this course. I found it fantastic”
- Lauren, Medical Student, Canada
"A thorough, convenient course that will help me educate my birth doula clients so they can make the best decisions for their own health and that of their babies."
- Susan, Birth Doula, San Francisco, USA
"Another amazing course from Toni and the Microbirth Team. I come away
from each course motivated and inspired and mostly grateful for such
interesting, relevant, and up to date information that I can share with
my clients in an easy to understand way. Look forward to the next one!"
- Michelle, Birth Doula, Japan
GROUP B STREP (GBS) ONLINE COURSE
For Health Professionals
Helping YOU feel more confident about group B Strep.
Helping YOU support parents with full informed choice.
Evidence-based with up-to-date references
Easy-to-understand & easy-to-digest
Go-at-your-own pace so you can take days, months or up to 3 years to complete course (and claim your CE credits!)
Learn from 5 world-leading professors and experts
Approved for 10 CPD HOURS / CE credits
Downloadable handouts & Certificate of Completion
Remember, this information can save lives.
Group B Strep is the leading cause
of serious infection (meningitis & sepsis)
in newborn babies.
Aimee was born 23rd July 2011 and very quickly developed early-onset GBS meningitis. Aimee was treated with IV antibiotics and survived. Aimee has severe quadiplegic spastic dystonia cerebral palsy affecting all four limbs, and pseudobulbar palsy affecting her eating and ability to talk. (Photo credit: Aimee's mother, Charlotte)
Approved Continuing Education for midwives, doulas,
childbirth educators and lactation consultants
Group B Strep (GBS) Online Course has been approved for:
10 CPD HOURS approved by the Australian College of Midwives (ACM)
10 HOURS approved by the Midwifery Council (New Zealand) Alto Films Ltd Approval Number: 2018CME038E
11.0 LAMAZE CONTACT HOURS approved by Lamaze International
11.0 CONTACT HOURS accepted by The International Childbirth Education Association (ICEA) #LIN 18-14
10.5 CERPS (8.5 R-CERPs & 2 L-CERPs) approved by
the International Board of Lactation Consultants Examiners (IBLCE)
Registry Number 320039K
This course can be used as 10 HOURS CPD for revalidation by the Nursing and Midwifery Council (NMC)
HOURS or 1.0 Midwifery CEU credits by the Midwifery Education &
Accreditation Council (
Program No MEAC ID #M2021-09-1010DE). These 10 HOURS / 1.0 Midwifery CEUs are applicable for Certified
Professional Midwives recertifying through the North American Registry of
If you are a midwife, lactation consultant, doula, childbirth educator or other health professional, the following CPD / CE credits are accepted by many midwifery, nursing, doula, childbirth education orgnanizations including: IBLCE, ACM, ICEA, DONA International, CAPPA and Lamaze International.
Group B Strep (GBS) Online Course
Accredited Continuing Education
from 5 leading group B Strep experts
VICTOR NIZET: Professor & Vice Chair for Basic Research, Department of Pediatrics & Chief, Division of Host-Microbe Systems & Therapeutics. And Professor, Skaggs School of Pharmacy & Pharmaceutical Sciences, University of California San Diego
MEGHAN AZAD: Assistant Professor of Pediatrics and Child Health at the University of Manitoba, Canada. Dr. Azad serves on the Executive Council for the International Society for Research in Human Milk and Lactation, and the Breastfeeding Committee of Canada.
ANITA KOZYRSKYJ: Professor in the Department of Pediatrics, University of Alberta, Canada. Dr Kozryskyj is the PI of SyMBIOTA (Synergy in Microbiota) research program, one of the seven CIHR-funded Canadian Microbiome Initiative teams
PHILIP STEER: Emeritus Professor of Obstetrics, Imperial College London. Dr Steer has authored 135 research papers, and many reviews, editorials and book chapters/books. Former Editor-in-Chief of BJOG – an International Journal of Obstetrics and Gynaecology, he is the current Chair of the GBS Support medical advisory panel.
JANE PLUMB MBE: Chief Executive, Group B Strep Support. A former member of the Department of Health priority setting workshops for GBS research and current member of the International Symposium on Streptococcus Agalactiae Disease scientific committee. Co-vice chair of the Royal College of Obstetricians & Gynaecologists’ Women’s Network.
Evidence-based visual presentations
combined with HD short videos
- For example, from Session 2 on group B Strep in newborns:
- Group B Strep and the human microbiome – including the microbial properties and the special virulence factors of GBS (learn what they are in the course!)
- Group B Strep and vaginal birth, C-section and preterm birth
- Explanation of ‘Universal Screening’ and ‘Risk-based’ approaches to prevent GBS infections
- Latest research on maternal IV antibiotics for GBS and the potential impact on the infant microbiome
- Latest research on breastfeeding and group B Strep
- Latest developments about a potential maternal GBS vaccine
- Clinical guidelines to prevent GBS infections for USA, Canada, Australia, New Zealand and UK
GROUP B STREP (GBS)
USD $80 / AUD $118 / CAD $107 / NZD $125 /
GBP £66 / EURO 73 / ZAR 1223 + local taxes
is a one-time purchase. There are no recurring fees.
Purchase of this course gives you access to the course content for 3 years.
- 10 HOURS CPD / CE / CERPs can be claimed when needed for re-certification.
- The usual price for this course is USD $247
- but we want to make this critical information affordable by all, so
we have discounted the price to USD $80 price for a limited time only.
For groups, the person who makes the purchase will be emailed access codes to distribute to all members of the group. Each group member will use the access code to create their own account. CPD/CEU credits are claimed by each individual upon completion of the course.
For larger groups of more than 10 people, including schools, colleges, universities or organisations, please CONTACT US for a bespoke quote.
- Groups of 10: USD $400 + local taxes
Get started now!
Preview1. Session One: Learning Objectives
Preview2. VIDEO: Why do you care about GBS? (2:56)
Preview3. What is group B Strep?
Preview4. VIDEO: What is group B Strep? (1:06)
Preview5. Microbial properties of group B Strep
Start6. VIDEO: Microbial properties of group B Strep (5:22)
Start7. GBS and the human microbiome
Start8. VIDEO: Group B Strep and the human microbiome (2:19)
Start9. Carrying GBS in the human microbiome
Start10. VIDEO: Difference between carrying group B Strep and having a group B Strep infection? (1:24)
Start11. How is GBS carriage detected?
Start12. VIDEO: Who is most vulnerable to GBS infections? (1:46)
Start13. GBS infection in adults
Start14. Session One: Science References
Start15. Session One: Graded Test
Start16. Session One: Downloadable Handouts
Start17. Session One: Discussion Forum
Start1. Session Two: Learning Objectives
Start2. VIDEO: GBS infection in newborns: A serious global problem (1:03)
Start3. Global statistics for carrying GBS in pregnancy
Start4. VIDEO: How can infants acquire group B Strep during labour and vaginal childbirth? (2:40)
Start5. How can infants acquire GBS during labour and vaginal birth?
Start6. VIDEO: How can infants acquire group B Strep after birth? (1:43)
Start7. How can infants acquire GBS after birth?
Start8. VIDEO: Risk of a newborn developing a GBS infection (3:22)
Start9. Risk of a newborn developing GBS infection
Start10. VIDEO: GBS infection and preterm birth (1:37)
Start11. GBS infection and preterm birth
Start12. VIDEO: GBS infection with C-section (0:49)
Start13. GBS and C-section
Start14. Session Two: Science References
Start15. Session Two: Graded Test
Start16. Session Two: Downloadable handouts
Start17. Session Two: Discussion Forum
course format is a mixture of evidence-based visual presentations,
short videos, graded tests, discussion forums, evaluations and
11 hours of course content delivered in short easy-to-undertand bite-sized learning sessions.
There's no deadline to complete the course so you can go-at-your-own pace
Each session includes picture and text-based PDF's, full HD short videos, discussion forums and quizzes
Full set of downloadable handouts including printable Certificate of Completion (with approved CE credits)
Review of Group B Strep (GBS) Online Course
Dianne Garland, Freelance Midwife, SRN RM ADM PGCEA MSc http://midwifeexpert.co.uk/
"As on line education becomes more popular this is the right time that a package on GBS is available.
Designed into sessions the introduction of how to use the package permits the learner the skills to traverse through the documents. The layout is clear, well designed with a balance between interviews and slides, which enhance each other and keep the learners attention as each is designed in small sessions.
The graphics on the slides are clear and the interviews from international speakers enhance the session presentation.
Each session is broken in individual sections which allows the learner to start and stop at their own speed.
The content is comprehensive including physiology, research and practical clinical advice. The international perspectives allow the learner to view the differences between five countries (UK, USA, Canada, Australia and New Zealand) but does not preclude the challenges in developing countries where neonatal sepsis is a huge issue.
Up to date information is shared about the microbiome, LSCS and breast feeding and the influence of GBS. Throughout the learning package there are learning outcomes, references and summary questions.
At the end of the learning package each of the expects summarise with take home messages – Breast feeding supports the microbiome, the differences between developed and developing countries, women need to be aware of GBS so they can make informed decisions and that choice and knowledge supports GBS recognition.
The research looking for a vaccine for GBS is discussed at the end of the package and opens the window on future management of GBS"
2nd February 2019
Get started now!
Philip Steer, Emeritus Professor of Obstetrics and Gynaecology, Imperial College London
Philip Steer is Professor Emeritus at Imperial College London, having been appointed Professor in 1989.
He was a consultant obstetrician for 35 years, based at the Chelsea and Westminster Hospital from 1994.
He has authored 135 research papers, and many reviews, editorials and book chapters/books. His particular interests are the pathophysiology of labour, maternal heart disease and pregnancy, and the role of GBS infection in pregnancy and labour.
He was Editor-in-Chief of BJOG – an International Journal of Obstetrics and Gynaecology - from 2005-2012, is now editor emeritus, and edits the ‘BJOG on the case’ series. He is currently an editor of ‘High Risk Pregnancy – Management Options’ with the fifth edition published by Cambridge University Press in 2017. He was President of the British Association of Perinatal Medicine from 1996 to 1999 and President of the Section of Obstetrics and Gynaecology of the Royal Society of Medicine from 2008 to 2009. He is an honorary member of the South African Society of Obstetricians and Gynaecologists, honorary fellow of the College of Obstetricians and Gynaecologist of South Africa, and an honorary fellow of the American Gynecological & Obstetrical Society. He has been the Chair of the GBS Support medical advisory panel since 2005
Professor Anita Kozyrskyj, Department of Pediatrics,
University of Alberta
Dr Kozyrskyj's epidemiological research uses
population-based birth cohort studies with linkage to existing
healthcare databases. Her research interests focus on early life
programming of childhood atopic disease and overweight, as influenced
by birth method, infant diet and antibiotic use during pregnancy,
birth and infancy.
Dr Kozryskyj is the PI of SyMBIOTA (Synergy in
Microbiota) research program, one of the seven CIHR-funded Canadian
Microbiome Initiative teams. The SyMBIOTA program, which derives its
data from the 4-site CHILD (Canadian Healthy Infant Longitudinal
Development) pregnancy cohort study, aims to investigate influences on infant gut microbiota and
the connection to the development of atopy and overweight.
Meghan Azad, Assist. Professor, Department of Pediatrics & Child Health, University of Manitoba
Assistant Professor, Department of Pediatrics & Child Health and Community Health Sciences, University of Manitoba; Associate Investigator, Canadian Healthy Infant Longitudinal Development (CHILD) Study, Research Scientist, Children’s Hospital Research Institute of Manitoba; co-Lead, Population Health Pillar, Developmental Origins of Chronic Diseases in Children Network (DEVOTION).
Dr Azad’s research focuses on the developmental origins of health and disease (DOHaD). Increasingly, early-life exposures are being linked to the development of non-communicable diseases throughout the life course. Perinatal exposures including parent lifestyle and diet, environmental chemicals, nutrition and the social environment have been identified as early determinants of chronic disorders including allergies, asthma, obesity, and cardiovascular disease. DOHaD research addresses these complex and long-term associations, seeking a better understanding of the underlying biological mechanisms with the ultimate goal of preventing disease through intervention during critical periods of early development.
Victor Nizet, Professor of Pediatrics and Pharmacy, University of California San Diego
Victor Nizet is currently Professor and Vice Chair for Basic Research and Chief of the Division of Host-Microbe Systems & Therapeutics at the University of California, San Diego (UCSD), School of Medicine as well as Professor at UCSD Skaggs School of Pharmacy & Pharmaceutical Sciences.
Dr. Nizet is a graduate of Reed College, received his medical training at Stanford University School of Medicine, completed a Residency and Chief Residency in Pediatrics at Harvard University's Children's Hospital in Boston, Massachusetts, and a then a Fellowship in Pediatric Infectious Diseases at the University of Washington’s Children's Hospital in Seattle. Dr. Nizet leads a large basic and translational research laboratory focused on discovering virulence factors of invasive bacterial pathogens, elucidating mechanisms of host innate immunity, and novel approaches to infectious disease therapy or vaccines, with a longstanding interest in newborn infections and group B Streptococcus (GBS). Dr. Nizet has authored over 410 peer-reviewed publications, and has collaborated with several biotechnology interests in developing new antibiotic and immune-based therapies against drug-resistant pathogens. Dr. Nizet's work has been recognized by an American Heart Association Established Investigator Award, the American Lung Association Career Investigator Award, the American Asthma Foundation Senior Investigator Award, the E. Mead Johnson Award for Research in Pediatrics, and he been elected to the American Society for Clinical Investigation, the Association of American Physicians, and the American Academy of Microbiology.
Dr. Nizet’s laboratory offers a variety of training opportunities for graduate and medical students, clinical fellows, and junior faculty from all over the world. Details of his research program can be found on the laboratory website: http://nizetlab.ucsd.edu
Jane Plumb, Chief Executive, Group B Strep Support
Jane and husband Robert founded Group B Strep Support (GBSS) in 1996,
following the death of their middle child.
GBSS is an independent UK
charity with a highly-respected and independent medical advisory panel
working to stop group B Strep infection in babies. The charity provides
information and support to families affected by group B Strep and their
health professionals, and supports relevant research. Jane has worked
with many UK medical bodies, contributing to group B Strep related
consultations, was a member of the UK National Screening Committee’s
Antenatal Care GBS subgroup, the HTA’s GBS Protocol Development Group,
the committees for NICE’s guideline and quality standard for Antibiotics
for Neonatal Infection, and for their guideline and quality standard
for Preterm Labour and Preterm Birth.
She has worked on a number of
research projects as co-applicant providing PPI support, including
DeVANI, HTA and other research. She was a member of the Department of
Health priority setting workshops for GBS research and is a member of
the International Symposium on Streptococcus Agalactiae Disease
She is co-vice chair of the Royal College of Obstetricians & Gynaecologists’ Women’s Network, and regularly speaks at conferences and events about group B Strep in the UK and internationally. Jane was awarded an MBE for services to Child Healthcare in 2012.
Why are we doing this?
Here’s an outline of our goals for our Group B Strep (GBS) Online Course.
- Group B Strep (GBS) is a complex, nuanced and difficult subject that can cause much confusion for many health professionals. Current clinical guidelines to prevent GBS infections can be a minefield to navigate. This means Group B Strep can be a conversation stopper, because many health professionals do not feel fully confident on the subject.
- Our Group B Strep (GBS) Online Couse sets out to explain in an easy-to-understand way the latest thinking on group B Strep, including an explanation of the latest evidence-based research, the current guidelines and practices in the UK, USA, Canada, Australia and New Zealand, and possible future developments to prevent group B Strep infections in newborns.
- The Group B Strep (GBS) Online Course is designed to help health professionals feel much more confident on this difficult subject, so they can be in a better position to empower parents with full informed choice. Our hope is that this course provides a platform for debate and discussion about whether current guidelines and practices need to be reviewed. We also hope the course will highlight the urgent need for much more research to help improve health outcomes for all mums and babies.
Toni Harman is the co-producer/director of the of the multi award-winning documentary MICROBIRTH and co-author of the books, THE MICROBIOME EFFECT (UK & World) & YOUR BABY'S MICROBIOME (US/Canada). Toni is the founder and course leader of MICROBIRTH SCHOOL (MICROBIOME COURSES).
Toni has been featured on BBC Radio 4 Woman's Hour, BBC Radio 5 Live, BBC World Service and appeared as a guest on numerous podcasts. Her work has been featured in The Observer, The Daily Telegraph and the Daily Mail. Toni has written blog-post articles for Scientific American and the Huffington Post. Toni has also been keynote speaker at several international scientific, midwifery and breastfeeding conferences.
You can contact Toni Harman via the contact form HERE.
This program has been approved for 10 CPD HOURS by the Australian College of Midwives (ACM)
program has been approved by
Lamaze International for 11.0 Lamaze
(LIN 18-14). These hours may be applied towards
recertification as an LCCE educator under the learning competencies 3
This program is accepted by The International Childbirth Education Association (ICEA) for 11.0 Contact Hours
program has been approved for
8.5 R-CERPs & 2 L-CERPs by
International Board of Lactation Consultants Examiners (IBLCE)
This event is approved as continuing midwifery education for 10 Hours by the Midwifery Council (New Zealand.) Alto Films Ltd Approval Number: 2018CME038E
This program has been approved for 10 Hours or 1.0 CEU by the Midwifery Education Accreditation Council (MEAC) MEAC ID #M2021-09-1010DE
This course can be used as 10 HOURS CPD for revalidation by the Nursing and Midwifery Council (NMC)
On completion of the course, a Certificate of Completion will automatically be generated (see below), or you can choose to download one of the other certificates with CE credits.
Additional Continuing Education Information
- 10.5 CERPs (1 L-CERP and 8.5 R-CERPs) can be used for
recertification for Lactation Consultants (IBCLC). Five years after most
recently passing the IBLCE certification exam, IBCLCs may renew their
certification by demonstrating completion of 75 hours of continuing education
that has been approved for CERPs. Of these, at least 50 must be L-CERPs. IBCLCs
recertifying by CERPs may use up to 20 R-CERPs to complete recertification
course is an Australian College of Midwives CPD
Recognised Activity and has been approved for 10 CPD
Hours. Australian Midwives and Nurses are required to collect 20 hours
Continuing Professional Development (CPD) each year, so this course will
provide 10 CPD Hours out of those 20 CPD Hours. If required for auditing,
the course certificate will provide date and number of CPD Hours. If
required for auditing, a brief description of objectives are listed at
the start of each course session.